Skip to main content

Table 1 Patient and tumor sample characteristics

From: Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma

Variable Overall N = 64 p-value
Age at diagnosis (in years) 55 (+/−15.1) 0.3
Sex   0.6
 Male 25 (39%)
 Female 39 (61%)
Race a   0.7
 White 40 (62.5%)
 Asian/PI 17 (26.6%)
 African American and Other 07 (10.9%)
Smoking history b   0.1
 No 37 (57.8%)
 Yes 20 (31.3%)
 Missing 07 (11.0%)  
Tumor stage c   0.005
 Early (Stage 2 or earlier) 22 (31.3%)
 Late (Stage 3 or later) 36 (56.3%)
 Missing 08 (12.5%)  
Tumor location   0.04
 Major salivary gland 19 (29.7%)
 Minor salivary gland 45 (70.3%)
Perineural invasion d   0.1
 Yes 41 (64.1%)
 No 11 (17.9%)
 Missing 12 (18.8%)  
Margin status e   0.2
 Negative 06 (09.4%)
 Positive 45 (70.3%)
 Missing 13 (20.3%)  
Dominant pattern   0.3
 Tubular/Cribriform 43 (67.2%)
 Solid 15 (20.3%)
 Missing 08 (12.5%)  
Tumor necrosis 13 (20.3%) 0.3
Treatment f   0.3
 Surgery 17 (26.6%)
 Surgery +RT/C or RT/C alone 47 (73.4%)
 Missing 01 (1.34%)  
  1. aThere were very few African American patients in our sample; thus, we combined them with people who disclosed their race as other, who were also few.
  2. bPatients were categorized as smokers if they reported current or formerly smoking.
  3. cTumor stages were determined clinically using TNM tumor classification.
  4. dPerineural invasion was determined histologically.
  5. eAll patients in our study received some treatment. We dichotomized them in two categories: those patients who received surgical treatment and those who underwent radiation therapy (RT) and chemotherapy (C) in addition to surgery or independent of surgical treatment.